C hronic inflammatory demyelinating polyneuropathy (CIDP)
is characterized by long-term sensory and motor dysfunction resulting from autoimmune attack of the peripheral nervous system (PNS) (1) . Two reports of CIDP in unrelated patients with autoimmune polyendocrinopathy syndrome type 1 (APS1), a disorder linked to mutations in the Aire gene, suggest a relationship between Aire and CIDP (2, 3) . In addition, we recently showed that a strain of NOD mice with a dominant G228W mutation (NOD.Aire GW/+ mice) develops spontaneous autoimmune peripheral neuropathy resembling CIDP (4, 5) . Thus, Aire dysfunction has been linked to PNS autoimmunity in both mice and humans.
In the thymus, Aire promotes ectopic expression of peripheral tissue Ags, which mediates the negative selection of self-reactive thymocytes (6, 7) . The dominant G228W mutation results in partial loss of Aire function, reducing expression levels of self-antigens to ∼10% of wild-type levels (5) . This decreased expression allows escape of self-antigen-recognizing T cells from thymic negative selection, which predisposes to autoimmune disease. A major selfantigens recognized by T cells in NOD.Aire GW/+ mice and APS1 patients with autoimmune peripheral neuropathy is myelin protein zero (P0), a PNS-specific protein (4) . NOD.Aire GW/+ mice express P0 in the thymus at greatly reduced levels, suggesting that ectopic P0 expression in the thymus is regulated by Aire (5) . Consistent with a defect in the negative selection of P0-specific T cells, increased peripheral T cell responses to P0 are seen in NOD.Aire GW/+ mice (4) .
The role of Aire in T cell negative selection suggests that T cell dysregulation underlies PNS autoimmunity in Aire deficiency. In addition, there is ample evidence that T cell dysregulation is a key component of PNS autoimmunity. For instance, in experimental allergic neuritis (EAN), an induced model of inflammatory demyelinating disease of the PNS, T cell-deficient mice are clinically and histologically unaffected by EAN compared with wild-type mice (8) . Also, in spontaneous models of PNS autoimmunity, T cells are sufficient to transfer neuropathy to immunodeficient recipients (4, 9) . Although the evidence for an important role of T cells in PNS autoimmunity is strong, how T cell costimulation impinges on PNS-specific T cells and how T cell inflammatory cytokine production directs neuropathy development require further clarification.
In addition to engagement of the TCR by Ag and MHC on the APC, costimulation is necessary for either the activation of naive T cells or immunoregulation in different disease settings. A prominent costimulatory interaction is between CD28 on CD4 + T cells and B7-1/B7-2 (CD80/CD86) on APCs (10, 11) . In certain autoimmune diseases, this interaction promotes autoimmune dis-ease development. For instance, in the adoptive-transfer model of experimental autoimmune encephalitis (EAE), blocking costimulation attenuates clinical outcomes of disease (12) , and genetic ablation of CD28 or B7-1/B7-2 confers resistance to disease (13) . Also, CD28 deficiency prevents the development of neuropathy in EAN, suggesting a pathogenic role for this costimulatory pathway in autoimmune peripheral neuropathy (14) . In addition to a proinflammatory role, this costimulatory interaction can dampen autoimmune disease development. For example, the same deficiencies of B7-1/B7-2 and CD28 in NOD mice cause an accelerated development of autoimmune diabetes (15) . Interestingly, genetic ablation of only B7-2 redirects autoimmunity from the pancreas to the peripheral nerves in NOD mice (9) . Thus, the way in which B7-1/B7-2 costimulation of T cells affects autoimmune disease development is not straightforward.
B7-CD28 costimulation of T cells has multiple effects on naive T cells, including modulation of T cell inflammatory cytokine production. CD28 stimulation acts through the AKT intracellular signaling pathway to increase production of IFN-g (16, 17) , and it enhances IFN-g promoter activity by 3-6-fold (18) . At the same time, T cells from NOD mice deficient in B7-1/B7-2 and T cells from EAN mice deficient in CD28 demonstrate decreased IFN-g production (14, 15) . Therefore, IFN-g production in these two autoimmune disease settings is promoted by T cell costimulatory activity.
Whether IFN-g exacerbates or protects from autoimmune peripheral neuropathy development is contentious. IFN-g was shown to be required for development of disease in both induced and spontaneous models of autoimmune peripheral neuropathy (19) (20) (21) . Conversely, Zhang et al. (22) recently reported that IFN-gdeficient mice developed exacerbated clinical symptoms of EAN, indicating a protective function of IFN-g. Although inconsistent with previous reports in autoimmune peripheral neuropathy, this protective role of IFN-g falls in line with evidence from other autoimmune diseases that are aggravated in the absence of IFN-g, such as EAE (23) , collagen-induced arthritis (24) , and rheumatoid arthritis (25) .
In this study, we focus on delineating how T cell IFN-g production and B7-CD28 costimulation affect development of spontaneous autoimmune peripheral neuropathy in NOD.Aire GW/+ mice. We demonstrate that genetic ablation of IFN-g prevents clinical, histological, and electrophysiological evidence of neuropathy in NOD.Aire GW/+ mice, which indicates that IFN-g is absolutely required for disease development. In contrast, deficiency of B7-2 alone and blockade of B7-1/B7-2 in combination significantly accelerate neuropathy development, pointing to a protective role for T cell costimulation in this model. Together, these results suggest that IFN-g production and B7-CD28 costimulatory pathways have distinct and potentially opposing effects on T cells in the development of autoimmune peripheral neuropathy.
Materials and Methods

Mice
NOD.Aire GW/+ mice were generated as previously described (5). NOD. IFNg 2/2 mice are from the Type-1 Diabetes Mouse Resource (The Jackson Laboratory). Because Aire and IFN-g are both on chromosome 10, NOD.Aire GW/+ IFNg 2/2 mice were generated from a founder mouse with crossover between these two loci. The line was continued by maintaining the mutant IFN-g locus in the homozygous state. NOD.B7-2 2/2 mice (9) were a gift from Dr. Jeffrey Bluestone (University of California, San Francisco [UCSF]). Mice in these experiments were backcrossed onto the NOD/ShiLtJ background for .10 generations. NOD.scid mice were purchased from The Jackson Laboratory. Mice were housed in a pathogen-free barrier facility at UCSF and University of North Carolina Chapel Hill.
Animals were assessed for clinical neuropathy and diabetes, as described (4). Mice were assessed at least once per week. Experiments complied with the Animal Welfare Act and the National Institutes of Health guidelines for the ethical care and use of animals in biomedical research.
Histology
Harvested organs were fixed in 10% formalin overnight, changed into 30% ethanol for 30 min, and then stored in 70% ethanol. Organs were embedded in paraffin, sectioned, and stained with H&E. Immune infiltration was scored in a blinded fashion using a system that was described previously (5) . Scores of 0, 1, 2, 3, and 4 indicate 0%, 25%, 50%, 75%, and .75% infiltration, respectively.
Intracellular cytokine staining
Intracellular cytokine staining and flow cytometry were performed as described (26) . Splenocytes were stained with anti-mouse CD3e (clone 145.2C11; eBioscience) and anti-mouse IFN-g (BD Biosciences) Abs and analyzed on a Cyan ADP Analyzer (Beckman Coulter).
Immunohistochemistry
Staining for immune cells in OCT-embedded sciatic nerves were performed with anti-CD4 (clone GK1.5; Bio X Cell) and anti-F4/80 (clone BM8; eBioscience) Abs, as described (26) . Staining for IP-10 was performed with anti-IP-10 Ab (R&D Systems), as described (27) .
Electrophysiology
Sciatic nerve conduction studies were performed as described (28) , using a Teca Synergy EMG system.
Adoptive transfer
Adoptive transfer of CD4 + T cells from spleen and lymph nodes of female neuropathic NOD.Aire GW/+ mice or age-matched IFN-g-deficient NOD.Aire GW/+ mice was performed, as described (4). CD4 + T cells were isolated using anti-CD4 MicroBeads (Miltenyi Biotec) on a MS or LS column. CD4 + T cells were activated in the presence of anti-CD3 and anti-CD28 (1 mg/ml in PBS) for 96 h. A total of 7 3 10 6 CD4 T cells was transferred retro-orbitally into female NOD.scid recipients
Ab treatment
Anti-B7-1 Ab (clone 16.10A1) and anti-B7-2 Ab (clone GL1) were generous gifts of Greg Szot (UCSF) or purchased from the UCSF Hybridoma Core. Fourteen-day-old mice were treated with 50 mg Ab or isotype control every other day for 10 treatments. For flow cytometry analysis of regulatory T cells (Tregs), mice were sacrificed 8 d after the last treatment.
Foxp3 staining
Thymocytes and lymphocytes were prepared for flow analysis, as described (26) . Cells were stained according to the manufacturer's instructions (eBiosciences) with fluorochrome-labeled Ab specific for mouse CD4 (clone RM4-5), CD8a (clone 53-6.7), CD25 (clone PC61.5), and Foxp3 (clone FJK-16a).
Real time RT-PCR
Fresh sciatic nerves were placed immediately into cell lysis buffer, and mRNA was isolated with the RNeasy Miniprep Kit (QIAGEN). The SuperScript VILO cDNA Synthesis Kit (Invitrogen) and TaqMan Universal PCR Master Mix (Applied Biosystems) were used for cDNA synthesis and PCR, respectively. Commercially available TaqMan primer-probe set (Applied Biosystems) for CXCL10 was used. Cyclophilin A was used as an internal control and detected with the primer-probe set reported by Su et al. (5) . Reactions were run on an ABI 7900HT Fast Real-Time PCR System (Applied Biosystems) and analyzed, as described (5).
Statistics
Data were analyzed with Prism software (GraphPad) using unpaired t tests. Log-rank tests were used for comparison of survival curves; p # 0.05 was considered significant. (Fig. 1B) (4) . Strikingly, however, none of the IFN-g-deficient NOD.Aire GW/+ mice developed clinical signs of neuropathy. Protection from clinical neuropathy was associated with absence of cellular immune infiltration within the sciatic nerves on H&E staining (Fig. 1C, 1D ). We previously reported that the immune infiltrates found in sciatic nerves of NOD.Aire GW/+ mice predominantly consist of CD4 + T cells and F4/80 + macrophages (4). Minimal CD4 and F4/80 expression could be detected by immunohistochemical staining within the sciatic nerves of IFN-gdeficient NOD.Aire GW/+ mice ( Fig. 1E ). Together, these data clearly demonstrate that IFN-g is necessary for the development of autoimmune peripheral neuropathy in NOD.Aire GW/+ mice. In addition to neuropathy, NOD.Aire GW/+ mice develop other autoimmune manifestations, including diabetes and sialitis (5), allowing us to simultaneously access the role of IFN-g in the development of these multiple autoimmune manifestations. In contrast to neuropathy, autoimmune diabetes developed at the same incidence in IFN-g-deficient NOD.Aire GW/+ mice as in IFN-g-sufficient NOD.Aire GW/+ controls ( Fig. 1F ). In addition, the severity of insulitis within the pancreas was unchanged, regardless of IFN-g status (Supplemental Fig. 1A, 1B) . Therefore, IFN-g is dispensable for the development of autoimmune diabetes in NOD.Aire GW/+ mice. This finding is consistent with reports that genetic deficiency of IFN-g or IFN-gR in NOD.WT mice does not significantly affect diabetes incidence (33) (34) (35) (36) . Furthermore, no changes in the development of sialitis, dacroadenitis, or uveitis were detected by histological analysis in IFN-g-deficient versus IFN-g-sufficient NOD.Aire GW/+ mice (Supplemental Fig. 1C , data not shown). Thus, among the autoimmune manifestations in NOD.Aire GW/+ mice, autoimmune peripheral neuropathy appears to be uniquely dependent on IFN-g.
Results
IFN-g is
Lack of IFN-g prevents development of electrophysiological abnormalities on nerve conduction studies in NOD.Aire GW/+ mice Nerve conduction studies of CIDP patients demonstrate characteristic findings of chronic demyelination (37) . These abnormalities include slowed conduction velocity and dispersion of compound muscle action potentials. To determine whether autoimmune peripheral neuropathy in NOD.Aire GW/+ mice results in electrophysiological changes, we performed nerve conduction studies, as described (28), on the sciatic nerves of .15-wk-old neuropathic NOD.Aire GW/+ mice and age-matched IFN-g-deficient NOD.Aire GW/+ mice. Studies on neuropathic NOD.Aire GW/+ mice demonstrated abnormalities indicative of predominantly demyelinating neuropathy, including reduced amplitude, slowed conduction velocity, and increased duration ( Fig. 2A, 2B, 2D ). In contrast, NOD.Aire GW/+ IFNg 2/2 sciatic nerves were indistinguishable from wild-type sciatic nerves (Fig. 2C, 2D ). Therefore, IFN-g deficiency prevents the development of the electrophysiological abnormalities seen in NOD.Aire GW/+ sciatic nerves. + T cells developed neuropathy by 6 wk posttransfer (Fig. 3A) . Consistent with this finding, dense immune infiltrates were seen on histologic sections of all sciatic nerves from recipients of IFN-g-producing CD4
+ T cells, whereas no immune infiltration was seen in any of the sciatic nerves from recipients of IFN-g-deficient CD4
+ T cells (Fig. 3B, 3C) . Thus, lack of IFN-g production by CD4
+ T cells prevents transfer of neuropathy.
Decreased IP-10 expression in sciatic nerves of NOD.Aire GW/+ mice lacking IFN-g IFN-g has a variety of effects on the immune response (38-41), one of which is the induction of chemokines required for immune cell targeting to tissues (42) (43) (44) . Of particular interest is the IFNg-inducible chemokine CXCL10/IP-10, which is highly expressed on endoneurial endothelial cells in inflammatory demyelinating neuropathies (45, 46) . Additionally, increased expression of IP-10 in nerves is associated with CIDP in humans (46) and with clinical neuropathy in NOD.Aire GW/+ mice (4). IP-10 promotes the transendothelial migration of macrophages and activated CD4 + T cells to sites of inflammation by binding to its receptor CXCR3 expressed on these immune cells (47) (48) (49) . In an EAE model, blocking IP-10 reduced the accumulation of immune cells within the CNS while increasing absolute splenocyte counts (47) . In NOD.Aire GW/+ mice, we also observed increased total splenocyte (Fig. 4A) and CD4 + T cell (Fig. 4B ) numbers in the setting of decreased immune infiltration within the sciatic nerves (Fig. 1C,  1E ). These similarities led us to hypothesize that IFN-g deficiency in NOD.Aire GW/+ mice may be associated with reduced IP-10 expression in sciatic nerves.
To test this hypothesis, we analyzed the relative expression of IP-10 in the sciatic nerves of neuropathic NOD.Aire GW/+ mice versus age-matched IFN-g-deficient NOD.Aire GW/+ mice. Immunohistochemical staining showed abundant IP-10 within the sciatic nerves of neuropathic NOD.Aire GW/+ mice and decreased IP-10 within the sciatic nerves of age-matched IFN-g-deficient NOD. Aire GW/+ mice ( (Fig. 4D) . As expected from our previously published data (4), IP-10 expression was low in young NOD.Aire GW/+ and young NOD.Aire GW/+ IFNg 2/2 mice. Increased IP-10 was not merely a baseline feature of the NOD strain, because aged IFN-g-sufficient NOD.Aire +/+ mice did not demonstrate increased IP-10 levels (Fig. 4D) . Interestingly, the IP-10 expression of aged NOD.Aire GW/+ IFNg 2/2 mice was not zero, suggesting a basal level expression that is not dependent on IFN-g. This is consistent Blockade of B7-1/B7-2 in NOD.Aire GW/+ mice results in fulminant, early-onset autoimmune peripheral neuropathy Previous work demonstrated that T cell IFN-g production is controlled, in part, by B7-1/B7-2 costimulation. In NOD mice, genetic ablation of both B7-1 and B7-2 resulted in decreased T cell IFN-g production (15) . Given our finding that IFN-g is absolutely required for neuropathy development, we sought to determine the effect of B7-1 and B7-2 blockade on neuropathy development in NOD.Aire GW/+ mice. Surprisingly, treatment of NOD.Aire GW/+ mice between 2 and 4 wk of age with anti-B7-1 and anti-B7-2 (anti-B7-1/B7-2) Abs resulted in fulminant early- (Fig. 5A) . NOD.Aire GW/+ mice became neuropathic at 8 wk of age, and 100% of mice were neuropathic by 11 wk. Treatment with anti-B7-1/B7-2 Abs accelerated neuropathy to a greater degree in NOD.Aire GW/+ mice than in wild-type mice, suggesting an additive effect of Aire deficiency and lack of costimulation in the development of autoimmune peripheral neuropathy. Manifestation of neuropathy was associated with severe immune infiltration of sciatic nerves (Fig. 5B, 5C ). Thus, despite decreased IFN-g production in NOD mice lacking B7-1/ B7-2 (15), blockade of B7-CD28 costimulation accelerated neuropathy development in NOD.Aire GW/+ mice. In addition to assessing neuropathy, we simultaneously monitored diabetes development in anti-B7-1/B7-2 Ab-treated mice. Genetic ablation of B7-1 and B7-2 in a mixed NOD-C57BL/6 strain was shown to result in early-onset autoimmune diabetes (15) . Consistent with this finding, treatment of wild-type NOD mice with anti-B7-1/B7-2 Abs resulted in early-onset autoimmune diabetes (Supplemental Fig. 2) , as previously reported (50) . In contrast, diabetes was not seen in any NOD.Aire GW/+ mice treated with anti-B7-1/B7-2 Abs. Thus, B7-1 and B7-2 blockade specifically accelerates neuropathy development without accelerating diabetes development in NOD.Aire GW/+ mice.
Blockade of B7-1/B7-2 in NOD.Aire GW/+ mice is associated with decreased Tregs B7-CD28 costimulation is required for the development and peripheral maintenance of CD4 + CD25
+ Tregs (15, 51, 52) . Treg population size was reported to be reduced by as much as 80% in NOD mice deficient in B7-1/B7-2 (10) and CD28 (15) . Therefore, we hypothesized that the acceleration of neuropathy seen in NOD.Aire GW/+ mice in the setting of B7-1 and B7-2 costimulation blockade may reflect a dependence on Tregs to delay neuropathy onset in NOD.Aire GW/+ mice. To test this possibility, NOD.Aire GW/+ mice were treated with anti-B7-1/B7-2 Abs, and Treg levels were measured 1 wk after the treatment course. Similar to NOD.WT mice, NOD.Aire GW/+ mice treated with anti-B7-1/B7-2 Abs demonstrated significantly decreased frequencies of Tregs in both the thymus and spleen compared with the isotype control-treated groups (Fig. 6A, 6B ). These findings suggest that the effect of anti-B7-1/B7-2 Abs on Treg frequency is not dependent on the presence of Aire. Additionally, the absolute number of Tregs in the thymus was significantly reduced in the anti-B7-1/B7-2 Ab-treated Aire GW/+ group (Fig. 6C) . In the spleen, there was ∼70% decrease in absolute numbers of Tregs in both the anti-B7-1/B7-2 Ab-treated NOD.WT and NOD.Aire GW/+ groups (Fig. 6C) . Although previous reports of Tregs in Aire-deficient mice indicate no change in Treg numbers (6, 7, 53, 54) , Lei et al. (55) recently reported that Aire-deficient mice have a reduction in the number of thymic Tregs. Consistent with this latter report, we also noticed a decrease in the absolute numbers of Tregs in the thymus of isotype control-treated NOD.Aire GW/+ mice compared with NOD.WT mice (Fig. 6C) . To investigate this further, we compared Treg numbers in untreated 8-wk-old NOD.WT and NOD.Aire GW/+ mice. Treg numbers were significantly lower in untreated NOD.Aire GW/+ thymi compared with NOD.WT thymi (Fig. 6D) . Thus, in line with the report of Lei et al. (55), NOD.Aire GW/+ mice demonstrate decreased numbers of thymic Tregs.
B7-2 deficiency and loss of Aire function have additive effects on the development of peripheral neuropathy
By itself, B7-2 deficiency in NOD mice (NOD.B7-2 2/2 mice) protects against autoimmune diabetes but redirects the autoimmune response toward the PNS (9). Lack of B7-2 may promote neuropathy development by upregulating B7-1 expression on CD11b + and CD11c + APCs within sciatic nerves (9) . Onset of spontaneous neuropathy in NOD.B7-2 2/2 mice occurs ∼7-10 wk later than in NOD.Aire GW/+ mice. To determine how B7-2 deficiency alone impinges on Aire-mediated spontaneous neuropathy development, we crossed NOD.B7-2 2/2 mice with NOD.Aire GW/+ mice to create NOD mice doubly deficient for Aire and B7-2. These mice developed neuropathy at an accelerated rate compared with singly Aire-deficient controls, with 100% of mice developing neuropathy by 19 wk of age (Fig. 7A, 7B ). This effect was more pronounced in male mice (Fig. 7B ) than in female mice (Fig. 7A ), although the difference was significant in both genders. Neuropathy was associated with sciatic nerve infiltration on histological analysis (Fig. 7C, 7D ). NOD.Aire GW/+ mice treated with an anti-B7-2-blocking Ab (GL-1) also displayed accelerated clinical neuropathy compared with those treated with isotype control (data not shown). The additive effects of these two immune tolerance defects suggest that Aire and B7-2 may function in two distinct pathways to prevent the development of autoimmune peripheral neuropathy.
Discussion
Autoimmune peripheral neuropathy in NOD.Aire GW/+ mice shares a number of features with human CIDP, including demyelination of peripheral nerves, immune infiltration consisting largely of CD4 + T cells and macrophages, and the clinical manifestation of chronic, bilaterally symmetrical weakness (4). Although the exact ) mice treated with either isotype control or a combination of anti-B7-1/B7-2 Abs (n = 8 and n = 7 for NOD wild-type mice treated with anti-B7-1/B7-2 Abs and isotype controls, respectively; n = 5 and n = 10 for NOD.Aire GW/+ mice treated with anti-B7-1/B7-2 Abs and isotype controls, respectively). *p , 0.007 for all curves compared with anti-B7-1/B7-2 Ab-treated NOD.Aire mechanism underlying autoimmune peripheral neuropathy is not fully understood, there is strong evidence for a critical role for T cells in disease development. Thus, understanding T cell activation and function in autoimmune peripheral neuropathy is key to understanding pathogenesis. In this study, we examine the roles of T cell inflammatory cytokine production and the B7-CD28 costimulatory pathway in the development of autoimmune peripheral neuropathy. We show that IFN-g is indispensable for immune infiltration of peripheral nerves and clinical neuropathy development in NOD.Aire GW/+ mice. Furthermore, transfer of disease by CD4 + T cells requires IFN-g production by T cells. In contrast, T cell costimulation by either B7-2 alone or B7-1/B7-2 in combination has immunoregulatory effects in autoimmune peripheral neuropathy, as indicated by the acceleration of autoimmune peripheral neuropathy in NOD.Aire GW/+ mice lacking these costimulatory signals. Thus, despite evidence that pathogenic IFN-g production is controlled, in part, by B7-1/B7-2 costimulatory signaling, IFN-g production and B7-CD28 costimulation have opposing effects on the development of autoimmune peripheral neuropathy.
Levels of inflammatory cytokines have been correlated with active disease in CIDP patients and animal models (32, 56) . However, the precise role of individual cytokines is not clear. A critical role for Th1 cytokines was demonstrated in both induced and spontaneous mouse models by delayed onset and reduced severity of neuropathy in mice deficient for IFN-gR (19) , 57) , and TNF-a (30) . At the same time, other reports suggest that production of the Th17 cytokine IL-17, and not IFN-g, is important in disease pathogenesis. Increased IL-17 production was associated with exacerbated EAN in the setting of IFN-g deficiency (22) , and IL-17 is the predominant cytokine in a spontaneous ICAM-1-deficient model of neuropathy (31) . Our study clearly shows that IFN-g is required for the development of autoimmune peripheral neuropathy in Aire-deficient NOD mice. The lack of neuropathy in IFN-g-deficient mice suggests that IL-17 cannot substitute for IFN-g in this model. Differences between our findings and other reports identifying IL-17 as a critical cytokine may lie in differences inherent to the models used in these studies.
Chemokines play an important role in immune cell trafficking, and IFN-g induces the production of a variety of chemokines, including IP-10 and RANTES (49, 58) . Importantly, mice deficient in the RANTES receptor CCR5 are not protected from EAN (27) , whereas IP-10-deficient mice are protected from demyelination and inflammatory cell infiltration (59) . Together, these findings suggest a critical role for IP-10, and not RANTES, in EAN development. Consistent with this, we show that IP-10 levels were significantly reduced in the sciatic nerves of IFN-g-deficient NOD.Aire GW/+ mice compared with age-matched, neuropathic NOD.Aire GW/+ mice. Taken together, these data suggest that the lack of IP-10 in IFN-g-deficient NOD.Aire GW/+ mice may prevent immune infiltration of the sciatic nerves.
Absence of CD28 signaling confers protection from EAN development (14) . In contrast, NOD mice deficient in B7-2 are protected from diabetes but develop spontaneous autoimmune peripheral neuropathy (9) . Thus, there is evidence that B7-CD28 costimulation has both a pathogenic and protective effect in autoimmune peripheral neuropathy. In this study, we show that lack of B7-1 and B7-2 accelerates disease, indicating a protective effect for B7-CD28 costimulation signaling in NOD.Aire GW/+ mice. This protective effect may be mediated by the B7-1/B7-2 signaling promotion of Treg development, because significantly fewer Tregs were observed in anti-B7-1/B7-2 Ab-treated NOD.Aire GW/+ mice compared with isotype control-treated NOD.Aire GW/+ mice. Moreover, the decrease in Tregs seen in NOD.Aire GW/+ mice compared with NOD.WT mice suggests that the more severe pathology observed in anti-B7-1/B7-2 Ab-treated NOD.Aire GW/+ mice compared with anti-B7-1/2 Ab-treated NOD.WT mice may be a result of the combined action on Tregs by costimulation blockade and Aire deficiency. In addition to its effects on Tregs, another possible mechanism by which blockade of B7-1/B7-2 signaling may accelerate neuropathy is by altering clonal deletion of autoreactive T cells in the thymus. Although some studies did not reveal a role for B7-1/B7-2 in thymic negative selection (60) (61) (62) , others showed that blocking B7-CD28 costimulation can result in the accumulation of self-reactive T cells in the thymus and that release of these T cells into the periphery can contribute to autoimmune disease pathogenesis (63) (64) (65) (66) (67) .
Multiple autoimmune diseases, including autoimmune neuropathy, diabetes, and sialitis, occur with high penetrance in NOD.Aire GW/+ mice, which allow us the unique opportunity to evaluate the effects of interventions on multiple diseases in parallel. Remarkably, the development of these diseases appears to be differentially regulated by T cell IFN-g production and costimulation blockade. Our data demonstrate that, although IFN-g production is absolutely required for neuropathy development, it is dispensable for autoimmune diabetes and sialitis development in NOD.Aire protected from the development of autoimmune diabetes. Additionally, our data reveal distinct effects of B7-CD28 costimulation on diabetes and neuropathy development in NOD.Aire GW/+ mice. Although lack of B7-1/B7-2 accelerates neuropathy development in NOD.Aire GW/+ mice, this deficiency does not accelerate diabetes development in these same mice. Together, these findings suggest that the multiple autoimmune manifestations in NOD.Aire GW/+ mice appear to be governed by distinct effector mechanisms.
Findings from this study have important implications for the potential treatment of patients with multiorgan autoimmunity, including APS1 patients. Modulating specific aspects of T cell function may have diverse effects on each individual autoimmune disease. For example, IFN-g blockade may have therapeutic efficacy in treating autoimmune peripheral neuropathy, but it is unlikely to have efficacy in other manifestations, such as sialitis. Indeed, in a case report of an APS1 patient treated with the immunosuppressant cyclosporine A, improvement in autoimmune gastrointestinal disease, keratoconjunctivitis, and alopecia universalis was seen. However, cyclosporine A treatment did not have an effect on autoimmune ovarian failure or adrenal disease (68) . Furthermore, some treatments may have opposite effects on different diseases. For instance, blockade of B7-2 in the B7-CD28 costimulatory pathway may ameliorate autoimmune diabetes, but accelerate autoimmune peripheral neuropathy development. Thus, the distinct and potentially opposing effects of T cell immunomodulatory agents on each individual affected organ need to be considered when treating patients with multiorgan autoimmunity.
